<DOC>
	<DOCNO>NCT01305954</DOCNO>
	<brief_summary>The primary purpose study measure association baseline expression senescence effector protein p16INK4a myelosuppression due chemotherapy patient breast cancer . Patients Stage I-IV breast cancer include myelosuppression assess first cycle chemotherapy via measurement absolute neutrophil count ( ANC ) measure one time day 7-11 post cycle one . Study subject also ask complete brief health behavior questionnaire gather information relevant variable .</brief_summary>
	<brief_title>Study P16 Gene Predictor Myelosuppression Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>≥ 18 year age ; Histologically confirm Stage IIV breast cancer ; ECOG Performance Status 03 ; Scheduled start new course chemotherapy neoadjuvant , adjuvant metastatic set newly diagnose recurrent disease ; Growth factor , e.g. , filgrastim , pegfilgrastim , allow , dose duration track . Absolute Lymphocyte Count ( ALC ) &gt; 500 cells/μL determine routine CBC differential ; Signed , IRB approve write informed consent . Presence acute , active infection ; History clonal bone marrow disorder ( i.e. , myelodysplastic myeloproliferative disorder , acute chronic leukemia ) ; Other comorbid illness would impair ability participate study ; Concurrent experimental therapy ( Note : concurrent biologic therapy IS permit , provide experimental ) . Prior current receipt histone deacetylase ( HDAC ) inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Breast</keyword>
	<keyword>Cancer</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>New Diagnosis</keyword>
	<keyword>Treatment</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Blood</keyword>
	<keyword>Blood Draw</keyword>
	<keyword>Lab Draw</keyword>
	<keyword>Gene</keyword>
	<keyword>Gene Therapy</keyword>
	<keyword>Geriatric</keyword>
	<keyword>Oncology</keyword>
	<keyword>Muss</keyword>
	<keyword>UNC</keyword>
	<keyword>North Carolina Cancer Hospital</keyword>
	<keyword>Initial Treatment</keyword>
	<keyword>CBC</keyword>
</DOC>